PPARG and diabetes mellitus: Rosiglitazone (RSG) is a kind of peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist, commonly used to treat type 2 diabetes mellitus (T2DM), which could enhance insulin sensitivity (Hiatt, Kaul & Smith, 2013).